相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diversity and versatility of p38 kinase signalling in health and disease
Begona Canovas et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Degradation of proteins by PROTACs and other strategies
Yang Wang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Emerging New Concepts of Degrader Technologies
Yu Ding et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse
Min Sung Gee et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease
Ursula A. Germann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats
Natalia A. Muraleva et al.
ANTIOXIDANTS (2020)
Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38
Klara Kirsch et al.
NATURE COMMUNICATIONS (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy
Ghazaleh Kheiri et al.
REVIEWS IN THE NEUROSCIENCES (2019)
Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities
Wing-Yu Fu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Yuan Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical drug development for dementia with Lewy bodies: past and present
Garam Lee et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Targeting the Post-translational Proteome with Intrabodies
Antonino Cattaneo et al.
TRENDS IN BIOTECHNOLOGY (2019)
Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies
Kevin H. Strang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Chemically induced proximity in biology and medicine
Benjamin Z. Stanton et al.
SCIENCE (2018)
Blocking p38 Signaling Reduces the Activation of Pro-inflammatory Cytokines and the Phosphorylation of p38 in the Habenula and Reverses Depressive-Like Behaviors Induced by Neuroinflammation
Ya-wei Zhao et al.
FRONTIERS IN PHARMACOLOGY (2018)
An exploratory clinical study of p38 kinase inhibition in Alzheimer's disease
Philip Scheltens et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia
Irfan Ullah et al.
SCIENTIFIC REPORTS (2018)
Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells
Qing Yu et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice
Yongli Xie et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease
Jong Kil Lee et al.
MOLECULES (2017)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Ting-Ting Chu et al.
CELL CHEMICAL BIOLOGY (2016)
Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors
Jinyuk Heo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation
Zeynep Yurtsever et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease
Arne A. Ittner et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors
Kathrin E. Martz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
Solveigh C. Koeberle et al.
NATURE CHEMICAL BIOLOGY (2012)
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Lenka Munoz et al.
NEUROPHARMACOLOGY (2010)
From nose to brain: understanding transport capacity and transport rate of drugs
Hongbing Wu et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Influence of anatomy and head position on intranasal drug deposition
Paul Merkus et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2006)
Active mutants of the human p38α mitogen-activated protein kinase
R Diskin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Kenneth Hensley et al.
JOURNAL OF NEUROCHEMISTRY (2003)
p38 MAP kinase is activated at early stages in Alzheimer's disease brain
AY Sun et al.
EXPERIMENTAL NEUROLOGY (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
p38 Activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis
B McLaughlin et al.
JOURNAL OF NEUROSCIENCE (2001)
分享论文
